Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | ACHE | P22303 | 1/20 | 0.48 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.46 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.46 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8323805 | 0.83 | KMT2A (0.51) | ACHE | |
| SCHEMBL8327679 | 0.81 | ALDH1A1 (0.53) | GAA | |
| SCHEMBL8327760 | 0.77 | DRD4 (0.60) | CYP2D6 | |
| SCHEMBL7983366 | 0.77 | CHRNB2 (0.59) | — | |
| SCHEMBL8970143 | 0.77 | ACHE (0.62) | ACHE | |
| SCHEMBL6267504 | 0.74 | CYP2D6 (0.72) | CYP2D6GAA | |
| SCHEMBL4854395 | 0.74 | GAA (0.59) | CYP2D6GAAACHE | |
| SCHEMBL25741919 | 0.74 | GAA (0.56) | CYP2D6GAAACHE | |
| SCHEMBL9598352 | 0.73 | ALDH1A1 (0.68) | CYP2D6GAAACHE | |
| SCHEMBL30657539 | 0.72 | CYP1B1 (0.62) | ACHE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0760368-B1 | PYRIMIDINE DERIVATIVES | NISSHIN FLOUR MILLING CO (JP) | 1999-07-28 | — | — | EP | disclosed |
| US-5736550-A | TREATMENT OF GASTROINTESTINAL TRACT DISORDERS | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1998-04-07 | — | — | US | disclosed |
| EP-0760368-A1 | NOVEL PYRIMIDINE DERIVATIVE | NISSHIN FLOUR MILLING CO., LTD. (JP) | 1997-03-05 | — | — | EP | disclosed |